J&J's pancreatic-enzyme treatment Pancreaze gains FDA approval

04/12/2010 | Reuters

The FDA approved Pancreaze for use in patients with cystic fibrosis and other conditions caused by pancreatic-enzyme deficiency. The treatment, developed by Johnson & Johnson, will compete with pancreatic-enzyme products from Eurand and Abbott Laboratories.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ